Birchview-Capital-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AXSM",
  "ALKS",
  "ACAD",
  "MASI",
  "APLS",
  "FOLD",
  "SWTX",
  "NVCR",
  "ARVN",
  "TVTX",
  "LQDA",
  "STOK",
  "KROS",
  "PRTA",
  "TSVT",
  "ALMS",
  "ATRA",
  "SRRK",
  "APGE",
  "INBX",
  "NBIX",
  "KALV",
  "LUNG",
  "TELA",
  "TMCI",
  "ZBIO",
  null,
  "BDSX",
  "IFRX",
  "TXG",
  "EQT",
  "OM",
  "UTHR",
  "PTGX",
  "ATEC",
  "PHR",
  "SLDB",
  "NPCE",
  null,
  "MLTX",
  "QURE",
  null,
  "GOSS",
  "WVE",
  null,
  null,
  null,
  "HROW",
  "OVV",
  "VTYX",
  "XENE",
  "ZNTL",
  "FHTX",
  "KIDS",
  "XNCR",
  "RARE",
  "HALO",
  "AXGN",
  "BCRX",
  "BPMC",
  "BMY",
  "CADL",
  "CSTL",
  "CMPX",
  "CORT",
  "CGEM",
  "CYTK",
  "DCGO"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 68
Total Value: 115165860
Accession Number: 0001618205-25-000002
Form Type: 13F-HR
CIK: birchview-capital-lp
Manager Name: Birchview-Capital-Lp

Data Enrichment

91% identified

62 identified6 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

68 positions • $115.2M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 4 of 4

Sort by:

Zenas BioPharma, Inc.

ZBIO|98937L105

Shares:16.5K

Value:$130.3K

% of Portfolio:0.1% ($130.3K/$115.2M)

48576U106

Shares:28.0K

Value:$104.7K

% of Portfolio:0.1% ($104.7K/$115.2M)

2seventy bio, Inc.

TSVT|901384107

Shares:15.5K

Value:$76.6K

% of Portfolio:0.1% ($76.6K/$115.2M)

ALUMIS INC.

ALMS|022307102

Shares:10.0K

Value:$61.4K

% of Portfolio:0.1% ($61.4K/$115.2M)

InflaRx N.V.

IFRX|N44821101

Shares:50.0K

Value:$51.0K

% of Portfolio:0.0% ($51.0K/$115.2M)

Compass Therapeutics, Inc.

CMPX|20454B104

Shares:24.0K

Value:$45.6K

% of Portfolio:0.0% ($45.6K/$115.2M)

Ventyx Biosciences, Inc.

VTYX|92332V107

Shares:28.8K

Value:$33.1K

% of Portfolio:0.0% ($33.1K/$115.2M)

Zentalis Pharmaceuticals, Inc.

ZNTL|98943L107

Shares:17.0K

Value:$27.0K

% of Portfolio:0.0% ($27.0K/$115.2M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Zenas BioPharma, Inc.(ZBIOcusip98937L105)	16.5K	QoQ 0.00% (-0) YoY NEW(+16.5K)	All Managers (Combined)	$130.3K	0.1% ($130.3K/$115.2M)	QoQ -3.54% (-$4.8K) YoY NEW(+$130.3K)
(cusip48576U106)✕	28.0K	QoQ -93.33% (-391.8K) YoY -94.04% (-441.8K)	All Managers (Combined)	$104.7K	0.1% ($104.7K/$115.2M)	QoQ -63.13% (-$179.3K) YoY -85.24% (-$604.8K)
2seventy bio, Inc.(TSVTcusip901384107)	15.5K	QoQ -2.10% (-333) YoY -21.84% (-4.3K)	All Managers (Combined)	$76.6K	0.1% ($76.6K/$115.2M)	QoQ +64.49% (-$30.0K) YoY -27.83% (-$29.5K)
ALUMIS INC.(ALMScusip022307102)	10.0K	QoQ 0.00% (-0) YoY NEW(+10.0K)	All Managers (Combined)	$61.4K	0.1% ($61.4K/$115.2M)	QoQ -21.88% (-$17.2K) YoY NEW(+$61.4K)
InflaRx N.V.(IFRXcusipN44821101)	50.0K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$51.0K	0.0% ($51.0K/$115.2M)	QoQ -58.70% (-$72.5K) YoY -33.76% (-$26.0K)
Compass Therapeutics, Inc.(CMPXcusip20454B104)	24.0K	QoQ NEW(+24.0K) YoY NEW(+24.0K)	All Managers (Combined)	$45.6K	0.0% ($45.6K/$115.2M)	QoQ NEW(+$45.6K) YoY NEW(+$45.6K)
Ventyx Biosciences, Inc.(VTYXcusip92332V107)	28.8K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$33.1K	0.0% ($33.1K/$115.2M)	QoQ -47.48% (-$30.0K) YoY -79.09% (-$125.3K)
Zentalis Pharmaceuticals, Inc.(ZNTLcusip98943L107)	17.0K	QoQ 0.00% (-0) YoY +6.25% (-1.0K)	All Managers (Combined)	$27.0K	0.0% ($27.0K/$115.2M)	QoQ -47.52% (-$24.5K) YoY -89.28% (-$225.1K)